An Open Parallel Study to Determine the Optimum Dosing Schedule for AS-101 in AIDS/ARC Patients
Condition(s):HIV InfectionsLast Updated:June 24, 2005Completed
Hide Studies Not Open or Pending
Condition(s):HIV InfectionsLast Updated:June 24, 2005Completed
Condition(s):HIV InfectionsLast Updated:November 1, 2021Completed
Condition(s):Neovascular Age-related Macular DegenerationLast Updated:November 4, 2020Completed
Condition(s):External Genital WartsLast Updated:November 1, 2016Unknown status
Condition(s):Wart; External Genital Organs; Condyloma AcuminataLast Updated:August 15, 2013Completed
Condition(s):Acute Myeloid Leukemia; Myelodysplastic SyndromeLast Updated:February 10, 2015Suspended
Condition(s):Atopic DermatitisLast Updated:July 17, 2014Terminated
Condition(s):Chemotherapy Induced ThrombocytopeniaLast Updated:June 21, 2011Terminated
Condition(s):Mild to Moderate PsoriasisLast Updated:July 23, 2015Withdrawn
Condition(s):AlopeciaLast Updated:January 4, 2007Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.